![]() Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. | ![]() Castle Biosciences Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers. | |
Founding Date | Founding Date 1993 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Friendswood, US HQ Phoenix, US |
Employees | Employees 878% decrease | Employees 61013% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 936.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) $344.2m (FY, 2025) |
Cost of goods | Cost of goods $28.4m (FY, 2022) | Cost of goods $71m (FY, 2025) |
Gross profit | Gross profit ($2.5m) (FY, 2022) | Gross profit $273.2m (FY, 2025) |
Net income | Net income ($32.1m) (FY, 2022) | Net income ($24.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 15.9m | Total funding raised $ 46.5m |

Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.
View company